Effects of a Differentiating Therapy on Cancer-Stem-Cell-Driven Tumors

To describe the effects of a differentiating agent that reprograms CSCs into differentiated cancer cells (DCC), researchers adapted a differential equation model developed to investigate tumorspheres, which were assumed to consist of jointly evolving CSC and DCC populations